These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 12924435)

  • 21. Chromosomal alterations detected by fluorescence in situ hybridization in urothelial carcinoma and rarer histologic variants of bladder cancer.
    Kipp BR; Tyner HL; Campion MB; Voss JS; Karnes RJ; Sebo TJ; Halling KC; Zhang J
    Am J Clin Pathol; 2008 Oct; 130(4):552-9. PubMed ID: 18794047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Urothelial neoplasms in individuals younger than 20 years show very few genetic alterations and have a favourable clinical outcome].
    Giedl J; Wild PJ; Stoehr R; Junker K; Boehm S; van Oers JM; Zwarthoff EC; Blaszyk H; Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI; Hartmann A
    Verh Dtsch Ges Pathol; 2006; 90():253-63. PubMed ID: 17867604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer.
    Friedrich MG; Erbersdobler A; Schwaibold H; Conrad S; Huland E; Huland H
    J Urol; 2000 Mar; 163(3):1039-42. PubMed ID: 10688045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toward the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer: comparative analysis with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing limitations.
    Zhang FF; Arber DA; Wilson TG; Kawachi MH; Slovak ML
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2317-28. PubMed ID: 9815630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].
    Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR
    Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of heterozygosity in primary lung cancer using laser capture microdissection and WAVE DNA fragment analysis techniques.
    Zhu W; Zou H; Beck A; Chervinsky D; Malik D; Brooks J; Tan D
    Med Sci Monit; 2002 Mar; 8(3):BR95-9. PubMed ID: 11889456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer.
    Stoehr R; Zietz S; Burger M; Filbeck T; Denzinger S; Obermann EC; Hammerschmied C; Wieland WF; Knuechel R; Hartmann A
    Eur Urol; 2005 Jan; 47(1):58-63. PubMed ID: 15582250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonality and genetic divergence in multifocal low-grade superficial urothelial carcinoma as determined by chromosome 9 and p53 deletion analysis.
    Hartmann A; Rösner U; Schlake G; Dietmaier W; Zaak D; Hofstaedter F; Knuechel R
    Lab Invest; 2000 May; 80(5):709-18. PubMed ID: 10830781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bladder cancer: allelic deletions at and around the retinoblastoma tumor suppressor gene in relation to stage and grade.
    Wada T; Louhelainen J; Hemminki K; Adolfsson J; Wijkström H; Norming U; Borgström E; Hansson J; Sandstedt B; Steineck G
    Clin Cancer Res; 2000 Feb; 6(2):610-5. PubMed ID: 10690546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laser microdissection and microsatellite analyses of breast cancer reveal a high degree of tumor heterogeneity.
    Wild P; Knuechel R; Dietmaier W; Hofstaedter F; Hartmann A
    Pathobiology; 2000; 68(4-5):180-90. PubMed ID: 11279344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract.
    Hafner C; Knuechel R; Zanardo L; Dietmaier W; Blaszyk H; Cheville J; Hofstaedter F; Hartmann A
    Oncogene; 2001 Aug; 20(35):4910-5. PubMed ID: 11521204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined genome-wide allelotyping and copy number analysis identify frequent genetic losses without copy number reduction in medulloblastoma.
    Langdon JA; Lamont JM; Scott DK; Dyer S; Prebble E; Bown N; Grundy RG; Ellison DW; Clifford SC
    Genes Chromosomes Cancer; 2006 Jan; 45(1):47-60. PubMed ID: 16149064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic aberrations are rare in urothelial neoplasms of patients 19 years or younger.
    Wild PJ; Giedl J; Stoehr R; Junker K; Boehm S; van Oers JM; Zwarthoff EC; Blaszyk H; Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI; Hartmann A
    J Pathol; 2007 Jan; 211(1):18-25. PubMed ID: 17072825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple mutation analyses in single tumor cells with improved whole genome amplification.
    Dietmaier W; Hartmann A; Wallinger S; Heinmöller E; Kerner T; Endl E; Jauch KW; Hofstädter F; Rüschoff J
    Am J Pathol; 1999 Jan; 154(1):83-95. PubMed ID: 9916922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noninvasive detection of alterations in chromosome numbers in urinary bladder cancer cells, using fluorescence in situ hybridization.
    Okamura T; Umemoto Y; Yasui T; Saiki S; Kuroda H; Kotoh S; Kamizaki H
    Int J Clin Oncol; 2004 Oct; 9(5):373-7. PubMed ID: 15549587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic modeling of human urinary bladder carcinogenesis.
    Czerniak B; Li L; Chaturvedi V; Ro JY; Johnston DA; Hodges S; Benedict WF
    Genes Chromosomes Cancer; 2000 Apr; 27(4):392-402. PubMed ID: 10719370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct microsatellite alterations in upper urinary tract tumors and subsequent bladder tumors.
    Takahashi T; Kakehi Y; Mitsumori K; Akao T; Terachi T; Kato T; Ogawa O; Habuchi T
    J Urol; 2001 Feb; 165(2):672-7. PubMed ID: 11176456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of fluorescence in situ hybridization, mtDNA quantification, and mtDNA sequence for the detection of early bladder cancer.
    Yoo JH; Suh B; Park TS; Shin MG; Choi YD; Lee CH; Choi JR
    Cancer Genet Cytogenet; 2010 Apr; 198(2):107-17. PubMed ID: 20362225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.